iRhythm Technologies Inc (IRTC)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.05B
Last updated: Nov 17, 2026 at 11:06 AM ET
iRhythm Technologies Inc (IRTC) Earnings: Report Dates and Results
iRhythm Technologies (IRTC) is expected to report earnings on Feb 17, 2027. In the quarter ended Sep 30, 2026, iRhythm Technologies reported EPS of $0.82. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IRTC has an expected report date of Feb 17, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 5.9% below the $0.17 reported for the quarter ended Dec 31, 2025.
IRTC Earnings Call
The latest IRTC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 37 quarters below that had an estimate, IRTC beat 18, missed 17 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $221.59M, up 14.9% from $192.88M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.82 | $0.02 | -$0.08 - $0.14 | N/A | N/A | N/A | 11 | N/A | Nov 5, 2026 | $221.59M |
| Jun 30, 2026 | $0.58 | -$0.01 | -$0.10 - $0.12 | N/A | N/A | N/A | 10 | 0 up, 0 down | Aug 6, 2026 | $224.17M |
| Mar 31, 2026 | -$0.35 | -$0.64 | -$0.90 - -$0.47 | +45.31% | Beat | N/A | 10 | 3 up, 5 down | Apr 30, 2026 | $199.39M |
| Dec 31, 2025 | $0.17 | $0.01 | -$0.11 - $0.27 | N/A | N/A | +1600.0% | 11 | 1 up, 2 down | Feb 19, 2026 | $208.89M |
| Sep 30, 2025 | -$0.06 | -$0.28 | -$0.47 - -$0.12 | +78.57% | Beat | N/A | 12 | 2 up, 2 down | Oct 30, 2025 | $192.88M |
| Jun 30, 2025 | -$0.32 | -$0.47 | -$0.63 - -$0.33 | +31.91% | Beat | N/A | 9 | 2 up, 4 down | Jul 31, 2025 | $186.69M |
| Mar 31, 2025 | -$0.95 | -$0.94 | -$1.20 - -$0.68 | -1.06% | Miss | N/A | 8 | 1 up, 0 down | May 1, 2025 | $158.68M |
| Dec 31, 2024 | $0.01 | -$0.28 | -$0.52 - -$0.03 | +103.57% | Beat | N/A | 9 | 0 up, 1 down | Feb 20, 2025 | $164.32M |
| Sep 30, 2024 | -$1.26 | -$0.57 | -$0.67 - -$0.46 | -121.05% | Miss | N/A | 9 | 0 up, 1 down | Oct 30, 2024 | $147.54M |
| Jun 30, 2024 | -$0.61 | -$0.88 | -$1.05 - -$0.78 | +30.68% | Beat | N/A | 10 | 1 up, 0 down | Aug 1, 2024 | $148.05M |
| Mar 31, 2024 | -$1.23 | -$0.99 | -$1.31 - -$0.70 | -24.24% | Miss | N/A | 8 | 1 up, 0 down | May 2, 2024 | $131.93M |
| Dec 31, 2023 | -$1.26 | -$0.60 | -$0.81 - -$0.25 | -110.00% | Miss | N/A | 8 | 0 up, 0 down | Feb 22, 2024 | $132.51M |
| Sep 30, 2023 | -$0.79 | -$0.58 | -$0.75 - -$0.55 | -36.21% | Miss | N/A | 8 | 1 up, 0 down | Nov 2, 2023 | $124.60M |
| Jun 30, 2023 | -$0.43 | -$0.75 | -$0.99 - -$0.62 | +42.67% | Beat | N/A | 8 | 0 up, 0 down | Aug 3, 2023 | $124.13M |
| Mar 31, 2023 | -$1.10 | -$0.86 | -$1.15 - -$0.73 | -27.91% | Miss | N/A | 10 | 0 up, 0 down | May 4, 2023 | $111.44M |
| Dec 31, 2022 | -$0.67 | -$0.62 | -$0.74 - -$0.57 | -8.06% | Miss | N/A | 11 | 0 up, 0 down | Feb 23, 2023 | $112.62M |
| Sep 30, 2022 | -$0.63 | -$0.81 | -$0.88 - -$0.79 | +22.22% | Beat | N/A | 10 | 0 up, 0 down | Nov 1, 2022 | $103.88M |
| Jun 30, 2022 | -$0.79 | -$0.90 | -$1.01 - -$0.81 | +12.22% | Beat | N/A | 9 | 1 up, 0 down | Aug 4, 2022 | $102.05M |
| Mar 31, 2022 | -$0.80 | -$1.06 | -$1.21 - -$0.90 | +24.53% | Beat | N/A | 9 | 1 up, 0 down | May 5, 2022 | $92.38M |
| Dec 31, 2021 | -$1.10 | -$1.17 | -$1.27 - -$0.69 | +5.98% | Beat | N/A | 9 | 1 up, 0 down | Feb 23, 2022 | $81.80M |
| Sep 30, 2021 | -$0.81 | -$1.07 | -$1.19 - -$1.01 | +24.30% | Beat | N/A | 9 | N/A | Nov 4, 2021 | $85.43M |
| Jun 30, 2021 | -$0.59 | -$0.94 | -$1.10 - -$0.76 | +37.23% | Beat | N/A | 10 | N/A | Aug 5, 2021 | $81.28M |
| Mar 31, 2021 | -$0.95 | -$0.85 | -$1.18 - -$0.40 | -11.76% | Miss | N/A | 10 | N/A | May 6, 2021 | $74.31M |
| Dec 31, 2020 | -$0.33 | -$0.31 | -$0.49 - -$0.10 | -6.45% | Miss | N/A | 11 | N/A | Feb 25, 2021 | $78.81M |
| Sep 30, 2020 | -$0.17 | -$0.52 | -$0.73 - -$0.26 | +67.31% | Beat | N/A | 11 | N/A | Nov 5, 2020 | $71.94M |
| Jun 30, 2020 | -$0.75 | -$0.75 | -$1.13 - -$0.53 | 0.00% | In line | N/A | 9 | N/A | Aug 6, 2020 | $50.88M |
| Mar 31, 2020 | -$0.34 | -$0.59 | -$0.78 - -$0.40 | +42.37% | Beat | N/A | 9 | N/A | May 7, 2020 | $63.53M |
| Dec 31, 2019 | -$0.65 | -$0.50 | -$0.61 - -$0.40 | -30.00% | Miss | N/A | 8 | N/A | Feb 27, 2020 | $59.10M |
| Sep 30, 2019 | -$0.74 | -$0.39 | -$0.44 - -$0.37 | -89.74% | Miss | N/A | 7 | N/A | Nov 5, 2019 | $54.67M |
| Jun 30, 2019 | -$0.46 | -$0.44 | -$0.48 - -$0.39 | -4.55% | Miss | N/A | 8 | N/A | Jul 31, 2019 | $52.44M |
| Mar 31, 2019 | -$0.33 | -$0.48 | -$0.56 - -$0.37 | +31.25% | Beat | N/A | 8 | N/A | May 7, 2019 | $48.33M |
| Dec 31, 2018 | -$0.48 | -$0.45 | -$0.51 - -$0.37 | -6.67% | Miss | N/A | 9 | N/A | Feb 12, 2019 | $41.78M |
| Sep 30, 2018 | -$0.43 | -$0.45 | -$0.50 - -$0.39 | +4.44% | Beat | N/A | 9 | N/A | Oct 30, 2018 | $38.44M |
| Jun 30, 2018 | -$0.51 | -$0.39 | -$0.48 - -$0.34 | -30.77% | Miss | N/A | 8 | N/A | Aug 1, 2018 | $35.29M |
| Mar 31, 2018 | -$0.47 | -$0.36 | -$0.44 - -$0.22 | -30.56% | Miss | N/A | 8 | N/A | May 2, 2018 | $31.76M |
| Dec 31, 2017 | -$0.48 | -$0.35 | -$0.38 - -$0.32 | -37.14% | Miss | N/A | 6 | N/A | Feb 14, 2018 | $28.80M |
| Sep 30, 2017 | -$0.29 | -$0.32 | -$0.33 - -$0.23 | +9.38% | Beat | N/A | 4 | N/A | Nov 1, 2017 | $25.04M |
| Jun 30, 2017 | -$0.29 | -$0.29 | -$0.31 - -$0.26 | 0.00% | In line | N/A | 4 | N/A | Aug 2, 2017 | $23.85M |
| Mar 31, 2017 | -$0.24 | -$0.35 | N/A | +31.43% | Beat | N/A | N/A | N/A | May 3, 2017 | $21.44M |
| Dec 31, 2016 | -$0.37 | -$0.27 | N/A | -37.04% | Miss | N/A | N/A | N/A | Feb 15, 2017 | $18.70M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.16, after -$3.09 the year before. It was -$3.17 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.16 | N/A |
| Dec 31, 2024 | -$3.09 | N/A |
| Dec 31, 2023 | -$3.58 | N/A |
| Dec 31, 2022 | -$2.89 | N/A |
| Dec 31, 2021 | -$3.45 | N/A |
| Dec 31, 2020 | -$1.59 | N/A |
| Dec 31, 2019 | -$2.18 | N/A |
| Dec 31, 2018 | -$1.89 | N/A |
| Dec 31, 2017 | -$1.30 | N/A |
| Dec 31, 2016 | -$3.17 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,500 words across 18 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,536 | 18 | |
| 2026Q2 | Jun 30, 2026 | 9,420 | 18 | |
| 2026Q1 | Mar 31, 2026 | 7,955 | 16 | |
| 2025Q4 | Dec 31, 2025 | 8,800 | 17 | |
| 2025Q3 | Sep 30, 2025 | 7,619 | 16 | |
| 2025Q2 | Jun 30, 2025 | 8,335 | 15 | |
| 2025Q1 | Mar 31, 2025 | 8,863 | 15 | |
| 2024Q4 | Dec 31, 2024 | 8,703 | 16 |
2026Q3 Earnings Call
Opening remarks
Francis Pruell Head of Strategic Finance and Investor Relations Thank you, operator, and thank you all for joining iRhythm's third quarter 2026 earnings call. With me today are Quentin Blackford, iRhythm's President and Chief Executive Officer; and Dan Wilson, our Chief Financial Officer. Before we begin, please note that management will make forward-looking statements within the meaning of federal securities laws under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding our intentions, beliefs, and expectations about future events, strategy, competition, products, operating plans, and performance. Forward-looking statements on this call are based on current estimates and assumptions, involve risks and uncertainties, and actual results may differ materially. These statements are made as of today, November 5, 2026, and are time sensitive. We undertake no obligation to update or revise them, except as required by law. Accordingly, you should not place undue reliance on these statements. For a discussion of risks and uncertainties, please refer to our most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and other filings with the SEC. Additionally, during the call, we will discuss certain financial measures that have not been prepared in accordance with GAAP. Unless otherwise noted, all references to financial measures on this call are presented on a non-GAAP basis. These non-GAAP measures should not be considered in isolation or as a substitute for or superior to GAAP results. Reconciliations to the most directly comparable GAAP measures can be found in our earnings release and the slides accompanying today's call. And with that, I'll turn the call over to Quentin.
Quentin Blackford President and Chief Executive Officer Good afternoon, everyone, and thank you for joining us for our third quarter earnings call. We are pleased with iRhythm's progress in the quarter, and our results reflect the positive growth trajectory of our business across multiple channels as well as the meaningful operating leverage we continue to generate as we scale the Zio platform. I'll begin with the key highlights from the quarter and provide updates on our strategic priorities before turning the call over to Dan for a more detailed review of our financial results and outlook. Third quarter revenue was $221.6 million, up nearly 15% year-over-year against our toughest comparison of the year as we lap more than 30% growth in the third quarter of 2025. Overall performance was consistent with our guidance, with our core Zio Monitor business again outperforming our expectations. That monitor business continues to be driven by durable demand and sustained momentum across primary care, innovative channels, and international markets. We continue to expand the cardiac diagnostics market, both within traditional cardiology settings and across these underpenetrated opportunities.
Frequently Asked Questions About IRTC
When is iRhythm Technologies's next earnings date?
iRhythm Technologies's next earnings report is expected for Feb 17, 2027.
What EPS do analysts expect from IRTC next quarter?
The consensus EPS estimate for iRhythm Technologies for the quarter ending Dec 31, 2026 is $0.16 from 18 analysts, with estimates from $0.05 to $0.31.
How often does IRTC beat earnings estimates?
iRhythm Technologies beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +17.96%.
IRTC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors